Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Wayne Brinster Joins WHEATON® as President

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.

WHEATON has announced the appointment of Wayne Brinster to the role of president, succeeding Stephen R, Drozdow, who remains as chief executive officer.

Mr. Brinster brings to the position a familiar, science-driven focus while sharing Mr. Drozdow’s long-time commitment to WHEATON customers, suppliers, partners and employees.

Mr. Brinster comes to WHEATON from Synthon Pharmaceuticals, a privately owned manufacturer of pharmaceutical and biopharmaceutical products, where he served as vice president and general manager.

Prior to Synthon, Mr. Brinster worked in different management roles for over 30 years at Becton, Dickinson and Company, where he most recently led the BD Diagnostics Women’s Health and Cancer Care initiative.

“Having spent most of my life in the business of science, I am excited to be here with a leading name in the field, joining an organization that has developed a reputation for supporting important scientific achievements,” said Mr. Brinster.

“By leveraging technical knowledge with excellent customer service, we’re going to continue placing WHEATON at the forefront of the industry,” he added.

Mr. Drozdow, after leading WHEATON since 1996, will become the chief executive officer and will continue to have an active role at WHEATON, working closely with Mr. Brinster on matters pertaining to strategy, key industry relationships, finance, budgets and acquisitions. “Wayne is a great business leader,” said Mr. Drozdow. “He understands the science of our markets, knows our industry and identifies with our approach to customers.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
NIH Sequences Genome of a Fungus
Researchers at the Institute have sequenced genome of human, mouse and rat Pneumocystis that cause life-threatening Pneumonia in immunosuppressed hosts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!